Enzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 Variants
Last enzo biochem, inc earnings: 12/7 04:10 pm
Check Earnings Report
US:NYSE Investor Relations: enzo.com/corporate/investor-information
Results indicate that GENFLEX meets new FDA guidance calling for COVID-19 test developers to assess the impact of viral mutations on testing results Company also publishes new corporate white paper outlining deficiencies in U.S. diagnostics sector’s response to COVID-19 and Enzo strategy results NEW YORK, NY, March 02, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced results of an analysis showing that tests processed on the Company’s proprietary GENFLEX™ molecular diagnostic platform are successfully able to detect the presence of currently known variants of COVID-19. While the Company’s PCR testing does not distinguish between different variants, positive samples can be further analyzed for variant identification. Rapid antigen tests currently available in the marketplace do not have this capability. On February 22, 2021, the US Food and Drug Administration issued new guid
[Read more]
| Impact snapshot | Event time: | ENZ | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
ENZ alerts
ENZ alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENZ alerts
High impacting Enzo Biochem, Inc news events
Weekly update
A roundup of the hottest topics
ENZ
News
- Enzo Biochem, Inc. (<a href="https://www.marketbeat.com/stocks/NYSE/ENZ/price-target/">NYSE: ENZ</a>) was upgraded by analysts at TheStreet from a "d+" rating to a "c" rating.MarketBeat
- ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUMGlobeNewswire
- Enzo Biochem, Inc. (ENZ) Q2 2021 Results - Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate UpdatesGlobeNewswire
- Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences ConferenceGlobeNewswire
- More
ENZ
SEC Filings
- 3/19/21 - Form 8-K
- 3/17/21 - Form SC
- 3/17/21 - Form 4
- ENZ's page on the SEC website
- More